Next report date
Report period
Q1 2024
EPS estimate
−0.04USD
Revenue estimate
21.53 MUSD
22.81 MUSD
96.74 MUSD
39.15 M
Om Spero Therapeutics, Inc.
Sektor
Bransch
VD
Satyavrat Shukla
Webbplats
Huvudkvarter
Cambridge
Employees (FY)
46
Grundat
2013
FIGI
BBG00HXSJ1R2
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
